The ToxTracker assay: a sensitive and specific reporter system for the identification of genotoxic and non-genotoxic carcinogens

Traditional in vitro genotoxicity tests, such as the Ames test or micronucleus assay, often suffer from low specificity and provide limited insight into the underlying mechanisms of toxicity. This study aimed to expand the ToxTracker assay—a mammalian stem cell-based reporter system—to provide a more comprehensive, mechanistic assessment of how chemicals disrupt cellular homeostasis and potentially induce cancer.

The researchers utilized mouse embryonic stem (mES) cells, which are genetically stable and proficient in essential stress-response pathways. They expanded their previously developed two-reporter system into a panel of six GFP-based reporter cell lines. Each reporter is linked to a biomarker gene specifically activated by distinct cellular stressors: DNA damage (BSCL2, RTKN), oxidative stress (SRXN1, BLVRB), the unfolded protein response (DDIT3), and a general p53-dependent stress response (BTG2). The team also developed 'Toxplot,' a software tool for automated data analysis and visualization, and validated the system using a large library of reference chemicals recommended by the European Centre for the Validation of Alternative Methods (ECVAM).

The expanded ToxTracker assay successfully discriminated between different primary reactivities of chemicals. For instance, it could distinguish between direct DNA-damaging agents and aneugenic compounds (mitotic spindle poisons) based on the differential activation of the BSCL2 and RTKN reporters. The assay demonstrated high sensitivity (95%) and specificity (94%) across the tested compound library. Furthermore, the researchers showed that the specificity of these reporters is largely independent of cytotoxicity levels, allowing for reliable identification of hazardous properties even at varying doses.

By identifying the specific biological pathways activated by a chemical, the ToxTracker assay helps toxicologists distinguish between genuine genotoxins and compounds that trigger false-positive results in conventional assays. This mechanistic insight is crucial for early-phase safety assessment in the pharmaceutical and chemical industries, enabling more accurate human hazard predictions and reducing the need for redundant animal testing.